Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Stem cell maintenance and disease progression in chronic myeloid leukemia.

Ito T.

Int J Hematol. 2013 Dec;98(6):641-7. doi: 10.1007/s12185-013-1318-8. Epub 2013 Apr 4. Review.

PMID:
23550022
2.

New strategies in the chemotherapy of leukemia: eradicating cancer stem cells in chronic myeloid leukemia.

Stefanachi A, Leonetti F, Nicolotti O, Catto M, Pisani L, Cellamare S, Altomare C, Carotti A.

Curr Cancer Drug Targets. 2012 Jun;12(5):571-96. Review.

PMID:
22414010
4.

A comparison of normal and leukemic stem cell biology in Chronic Myeloid Leukemia.

Jørgensen HG, Holyoake TL.

Hematol Oncol. 2001 Sep;19(3):89-106. Review.

PMID:
11574931
5.

Chronic myeloid leukemia stem cells and developing therapies.

Donato NJ, Peterson LF.

Leuk Lymphoma. 2011 Feb;52 Suppl 1:60-80. doi: 10.3109/10428194.2010.546921. Review.

PMID:
21299460
6.

Molecular pathogenesis of Philadelphia-positive chronic myeloid leukemia - is it all BCR-ABL?

Rumpold H, Webersinke G.

Curr Cancer Drug Targets. 2011 Jan;11(1):3-19. Review.

PMID:
21062244
7.

Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies.

Warmuth M, Danhauser-Riedl S, Hallek M.

Ann Hematol. 1999 Feb;78(2):49-64. Review.

PMID:
10089019
8.

Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.

Järås M, Johnels P, Hansen N, Agerstam H, Tsapogas P, Rissler M, Lassen C, Olofsson T, Bjerrum OW, Richter J, Fioretos T.

Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16280-5. doi: 10.1073/pnas.1004408107. Epub 2010 Aug 30.

9.

Signaling pathways in chronic myeloid leukemia and leukemic stem cell maintenance: key role of stromal microenvironment.

Seke Etet PF, Vecchio L, Nwabo Kamdje AH.

Cell Signal. 2012 Sep;24(9):1883-8. doi: 10.1016/j.cellsig.2012.05.015. Epub 2012 May 31. Review.

PMID:
22659137
10.

Characterization of cancer stem cells in chronic myeloid leukaemia.

Jørgensen HG, Holyoake TL.

Biochem Soc Trans. 2007 Nov;35(Pt 5):1347-51. Review.

PMID:
17956348
11.

Chronic myelogenous leukemia: molecular and cellular aspects.

Pasternak G, Hochhaus A, Schultheis B, Hehlmann R.

J Cancer Res Clin Oncol. 1998;124(12):643-60. Review.

PMID:
9879825
12.

[Molecular pathogenesis of chronic myeloid leukemia].

Sasaki K, Mitani K.

Nihon Rinsho. 2009 Oct;67(10):1894-9. Review. Japanese.

PMID:
19860186
13.

Chronic myeloid leukemia stem cells.

Kavalerchik E, Goff D, Jamieson CH.

J Clin Oncol. 2008 Jun 10;26(17):2911-5. doi: 10.1200/JCO.2008.17.5745. Review.

PMID:
18539972
14.

Novel combination treatments targeting chronic myeloid leukemia stem cells.

Al Baghdadi T, Abonour R, Boswell HS.

Clin Lymphoma Myeloma Leuk. 2012 Apr;12(2):94-105. doi: 10.1016/j.clml.2011.10.003. Epub 2011 Dec 16. Review.

PMID:
22178144
15.

Molecular biology of chronic myeloid leukemia.

Maru Y.

Int J Hematol. 2001 Apr;73(3):308-22. Review.

PMID:
11345196
16.

The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells.

Kobayashi CI, Takubo K, Kobayashi H, Nakamura-Ishizu A, Honda H, Kataoka K, Kumano K, Akiyama H, Sudo T, Kurokawa M, Suda T.

Blood. 2014 Apr 17;123(16):2540-9. doi: 10.1182/blood-2013-07-517847. Epub 2014 Feb 26.

17.

JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia.

Warsch W, Walz C, Sexl V.

Blood. 2013 Sep 26;122(13):2167-75. doi: 10.1182/blood-2013-02-485573. Epub 2013 Aug 7. Review. Erratum in: Blood. 2014 May 8;123(19):3056.

18.

Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML).

Scherr M, Chaturvedi A, Battmer K, Dallmann I, Schultheis B, Ganser A, Eder M.

Blood. 2006 Apr 15;107(8):3279-87. Epub 2005 Nov 8.

19.

BCR-ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia.

Roy S, Jørgensen HG, Roy P, Abed El Baky M, Melo JV, Strathdee G, Holyoake TL, Bartholomew C.

Br J Haematol. 2012 May;157(4):446-56. doi: 10.1111/j.1365-2141.2012.09078.x. Epub 2012 Feb 29.

PMID:
22372463

Supplemental Content

Support Center